Inventor · disambiguated record
Jason Burch
Also filed as: BURCH JASON · BURCH JASON DAVID
18 granted patents·17 pending applications·102 citations·filing 2006–2024
92Inventor score
Files withGENENTECH INC12VENTUS THERAPEUTICS U S INC8ALTMAN MICHAEL D3MERCK CANADA INC3MERCK SHARP & DOHME3
Top patents by PatentIndex Score
35 records- 0193US8735417B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2010·Granted May 27, 2014·35 cites·13 claims
- 0292US9353066B2Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 31, 2016·11 cites·19 claims
- 0392US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 0491US11066405B2Bicyclic compounds and their use in the treatment of cancerTEMPEST THERAPEUTICS INC·Filed 2020·Granted Jul 20, 2021·3 cites·16 claims
- 0588US9605005B2Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Granted Mar 28, 2017·5 cites·4 claims
- 0686US12410167B2Pyridazine compounds for inhibiting NLRP3VENTUS THERAPEUTICS U S INC·Filed 2023·Granted Sep 9, 2025·0 cites·17 claims
- 0786US11638704B2Bicyclic compounds and their use in the treatment of cancerTEMPEST THERAPEUTICS INC·Filed 2021·Granted May 2, 2023·1 cites·18 claims
- 0885US2024158396A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 0983US8486975B2Non-nucleoside reverse transcriptase inhibitorsBURCH JASON·Filed 2011·Granted Jul 16, 2013·9 cites·6 claims
- 1080US11738009B2Bicyclic compounds and their use in the treatment of cancerTEMPEST THERAPEUTICS INC·Filed 2018·Granted Aug 29, 2023·1 cites·11 claims
- 1180US9376418B2Substituted pyridine spleen tyrosine kinase (SYK) inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jun 28, 2016·5 cites·18 claims
- 1277US2022340567A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Application pending·0 cites
- 1374US8003661B2Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonistsMERCK CANADA INC·Filed 2008·Granted Aug 23, 2011·2 cites·14 claims
- 1473US8013159B2Quinoline derivatives as EP4 antagonistsMERCK CANADA INC·Filed 2006·Granted Sep 6, 2011·2 cites·17 claims
- 1571US9487504B2Imidazolyl analogs as syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·1 cites·7 claims
- 1670US9328106B2Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2013·Granted May 3, 2016·1 cites·23 claims
- 1765US2024368131A1Oxoindolinyl amide derivatives for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 1864US8969394B2Thiophenecarboxamide derivatives as EP4 receptor ligandsBLOUIN MARC·Filed 2007·Granted Mar 3, 2015·1 cites·18 claims
- 1964US2024270740A1Inhibitors of cyclic gmp-amp synthase and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 2060US2025179079A1Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulatorsVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 2158US2016096850A9Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2258US2025002487A1Heterocyclic compounds and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Application pending·0 cites
- 2358US2015057260A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2456US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 2554US2024018138A1PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALSVENTUS THERAPEUTICS U S INC·Filed 2021·Application pending·0 cites
- 2652US2017210724A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2752US2017145034A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2851US8685999B2Beta carboline sulphonylurea derivatives as EP4 receptor antagonistsBERTHELETTE CARL·Filed 2009·Granted Apr 1, 2014·0 cites·17 claims
- 2949US2016185797A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Application pending·0 cites
- 3045US9931323B2Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2016·Granted Apr 3, 2018·0 cites·21 claims
- 3145US2013296382A1Non-nucleoside reverse transcriptase inhibitorsMERCK CANADA INC·Filed 2013·Application pending·0 cites
- 3244US2014309210A1Indazole compounds, compositions and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 3344US2016326142A1Pyrazole carboxamide compounds, compositions and methods of useGENENTECH INC·Filed 2016·Application pending·0 cites
- 3440US2015158851A1Pyrazole carboxamide compounds, compositions and methods of useGENENTECH INC·Filed 2015·Application pending·0 cites
- 3539US9963446B2Oxepan-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2016·Granted May 8, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Jason Burch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →